Aleeza Furman

Aleeza Furman

Aleeza Furman is a Philadelphia-based litigation reporter with The Legal Intelligencer. Contact her at [email protected].

Connect with this author

May 10, 2024 | The Legal Intelligencer

Phila. Jury Hits ExxonMobil With $725.5M Verdict Over Carcinogen in Gasoline

The jury determined that Paul Gill developed acute myeloid leukemia as a result of his exposure to ExxonMobil's product, awarding $725 million in compensatory noneconomic damages for Gill, plus $500,000 to his wife for loss of consortium.

By Aleeza Furman

3 minute read

May 09, 2024 | The Legal Intelligencer

Judge Expands Ozempic Plaintiffs' Leadership Team, Names 4 Co-Lead Counsel

In a joint statement, the newly appointed leads said they "are honored to have been appointed by Judge Pratter to lead one of the most significant and consequential pharmaceutical injury cases of our time against the manufacturers of diabetes and weight loss drugs such as Ozempic and Wegovy."

By Aleeza Furman

3 minute read

May 07, 2024 | The Legal Intelligencer

'Incredible and Gross Negligence': Pa. Federal Judge Sanctions Ikea for Destroying Evidence

Brody ruled that Ikea's deletion of four email accounts significantly prejudiced the plaintiffs, and the company's "conduct and strategy of delay and obfuscation since plaintiffs first inquired about the deleted accounts in January 2023 displayed a lack of candor that is offensive to a court."

By Aleeza Furman

3 minute read

May 06, 2024 | The Legal Intelligencer

Disciplinary Court: Phila. Judge Violated Conduct Rules With Politically Charged Facebook Posts

The case is the first in Pennsylvania to grapple with what a judge may or may not post on social media. At the heart of the matter is a question of where the line lies between impropriety and a judge's protected free speech.

By Aleeza Furman

3 minute read

May 06, 2024 | The Legal Intelligencer

Group of Fired Scientists Win $26.6M Bucks County Verdict on Counterclaims Against Ex-Employer

The plaintiff alleged in its $849 million suit that its former employees stole trade secrets and set up competing drug companies.

By Aleeza Furman

3 minute read

May 03, 2024 | New Jersey Law Journal

'They Would Be Our Adversary': Beasley Allen's Andy Birchfield Testifies in Talc DQ Hearing

Johnson & Johnson alleges that Birchfield breached his ethical duties by partnering with Legacy Liability Solutions CEO James Conlan, who was outside counsel to Johnson & Johnson while a partner at Faegre Drinker Biddle & Reath until 2022, to push a $19 billion talc settlement proposal.

By Aleeza Furman

4 minute read

May 02, 2024 | The Legal Intelligencer

Pa. High Court Agrees to Eye Whether Employer Must Pay for Injured Worker's CBD Oil

According to claimant Mark Schmidt, the court's phrasing of the question was broader than what his employer raised in its appeal, expanding the issue to encompass an employer's duty to reimburse injured workers for not just CBD oil, but any type of over-the-counter item.

By Aleeza Furman

3 minute read

May 01, 2024 | The Legal Intelligencer

'It Wasn't About the Medicine': Western Pa. Jury Awards $7M Verdict for Delayed Cancer Diagnosis

"It's an important case for the medical community to take a look at because these PAs are not doctors," Richard Godshall said. "They're being put in position to make decisions that their experience and training just hasn't met yet."

By Aleeza Furman

3 minute read

April 30, 2024 | The Legal Intelligencer

Phila. Judge Rejects Challenge to $977M Defective Seatbelt Verdict, Adds $33.4M in Delay Damages

"Mitsubishi Motors respectfully disagrees with the trial court's decision to uphold the verdict and intends to appeal to the Superior Court of Pennsylvania," counsel for the defendant said in a statement.

By Aleeza Furman

4 minute read

April 30, 2024 | The Legal Intelligencer

'Urgent Need for Clarity': Mass Tort Defendant Presses Superior Court to Examine Pa.'s Registration Statute

"To provide much needed constitutional clarity after Mallory and conclusively resolve the jurisdictional status of nearly 90% of the total plaintiffs in the Paraquat mass tort program, this court should grant Syngenta Crop's petition for permission to appeal," the defendant argued.

By Aleeza Furman

3 minute read


NEXT